• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

Corresponding author: zhao si lin, 270315298@qq.com
DOI: 10.12201/bmr.202602.00043
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: (1.Hunan University of Chinese Medicine, Hunan Changsha 410208, China;2.The First Clinical Medical College of Hunan University of Chinese Medicine,Hunan Changsha 410007,China) Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease of unknown cause, and its pathological evolution highly aligns with the transformation from lung paralysis to lung wither in traditional Chinese medicine. The theory of restraining excessiveness to acquire harmony reveals the dynamic balance between the harm caused by excess and restraint and repair under pathological conditions in the human body. Based on this, the traditional Chinese medicine pathogenesis of IPF is analyzed, and its disease course is divided into three stages: the Lung Paralysis and Excess-Harm Stage, the Transition from Paralysis to Withering Stage, and the Lung Wither and Regulation-Collapse Stage. A stepwise treatment strategy of Reducing Excess, Restoring Balance, and Reinforcing the Foundation is systematically proposed: the first focuses on eliminating pathogens while facilitating regulation; the second on harmonizing restraint and repair by combining attack and tonification; and the third on consolidating the root to rescue the system and maintain residual regulatory function. This provides a new perspective for the traditional Chinese medicine diagnosis and treatment of this disease.

    Key words: idiopathic pulmonary fibrosis; restraining excessiveness to acquire harmony; staging treatment; lung paralysis; lung wither

    Submit time: 11 February 2026

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • Wangqimei, JIA Huitong, ZU-Di, HU Dongnan. Exploring the Pathogenesis, Syndrome Differentiation and Treatment of Idiopathic Pulmonary Fibrosis Based on the Theory of ascending lucidity and descending turbidity. 2026. doi: 10.12201/bmr.202602.00072

    Cai Xudong. Macrophage Polarization Affects Chronic Kidney Disease:Based on Theory of “Harmful Hyperactivity and Responding Inhibition”. 2024. doi: 10.12201/bmr.202407.00027

    DuYuPeng, LinYan. Exploration of Diagnostic and Treatment Experience in Two Cases of Idiopathic Retroperitoneal Fibrosis. 2024. doi: 10.12201/bmr.202410.00077

    Guan Wei, Xue Xiaoming. Progress of Trditional Chinese Medicine Targeting Alveolar Epithelial Cell Senescence in the Treatment of Pulmonary Fibrosis. 2025. doi: 10.12201/bmr.202506.00012

    成航, Wa Yongfang, Li Yan. Based on the excessive damage and subsequent regulation theory and the iron death mechanism, this paper discusses the etiology and pathogenesis of gouty arthritis and its diagnosis and treatment. 2025. doi: 10.12201/bmr.202512.00037

    LIANG Ningjuan, WU Ting, YU Dandan, JIANG Xiaohan, TENG Jingjing. Effective exploration of the toxicity and molecular mechanisms of plasticisers in pulmonary fibrosis by network toxicology and molecular docking strategies: an example of butylbenzyl phthalate. 2025. doi: 10.12201/bmr.202504.00004

    zhaofenqin. . 2025. doi: 10.12201/bmr.202501.00040

    guoxiaochen, wangpengfei, chenxiu, wuxinyao, zouchunpengchun, 徐茂晟. The value of SWE in early liver and kidney fibrosis in MAFLD. 2024. doi: 10.12201/bmr.202409.00010

    LiuChengxin, ZhengAihua. Based on The Theory of Lung and Intestine Treatment, The Treatment Experience of Shengxue Tongbian Granules for Acute Lung Injury of Sepsis was explored*. 2025. doi: 10.12201/bmr.202509.00041

    Lan Lingyan, Shu Qijin. Experience in Staged Treatment of Lung Cancer Treatment–Related Palpitations Based on the Theory of “Deficiency of Collaterals with Toxin Accumulation”. 2026. doi: 10.12201/bmr.202601.00067

  • ID Submit time Number Download
    1 2026-01-28

    10.12201/bmr.202602.00043V1

    Download
  • Public  Anonymous  To author only

Get Citation

zhao si lin. [title missed]. 2026. biomedRxiv.202602.00043

Article Metrics

  • Read: 37
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误